Research And Development Tenders

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Molsidomine, Atc C01dx12 for the Period May 1, 2024 - April 30, 2026

Open House Drug Discount Agreements Levothyroxine Sodium, Atc H03aa01

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Trientine, Atc A16ax12 for the Period May 1, 2024 - April 30, 2026

Open House Drug Discount Agreements Atovaquone, Atc P01ax06

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Sofosbuvir and Velpatasvir, Atc J05ap55 for the Period May 1, 2024 - April...

Medicine Discount Contracts in Accordance with Section 130A Paragraph 8 Sgb V as Part of Open House Procedures

Qualification System: Delivery, Assembly and Commissioning of Air-Insulated 10 Kv Circuit Breaker Systems

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V (Open House Model)

Modernization of the Central Pharmacy

Open House Contracts for Several Active Ingredients/Combinations of Active Ingredients